(Q35708587)

9 August 2017

1 reference

title

Gleevec: prototype or outlier? (English)

1 reference

9 August 2017

1

William G Kaelin

1 reference

9 August 2017

16 March 2004

1 reference

Science's STKE : signal transduction knowledge environment

9 August 2017

1 reference

9 August 2017

2004

1 reference

9 August 2017

pe12

1 reference

9 August 2017

225

1 reference

The protein kinase complement of the human genome

9 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

David A. Karnofsky Award lecture. Imatinib as a paradigm of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Roles of PDGF in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Cycling, stressed-out and nervous: cellular functions of c-Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Using cancer genetics to guide the selection of anticancer drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Familial gastrointestinal stromal tumours with germline mutation of the KIT gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Mutational analysis of the tyrosine kinome in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2252004PE12

Mining the human "kinome"

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/STKE.2252004PE12

Identifiers

DOI

10.1126/STKE.2252004PE12

1 reference

9 August 2017

1 reference

PubMed ID

15039489